Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login


Fewer than 3% of patients with type 3c diabetes are correctly diagnosed, study finds

Recently identified third type of diabetes misdiagnosed as type 2 in 97% of cases, British research shows.

The majority of cases of type 3c diabetes in England are being misdiagnosed by clinicians as type 2 diabetes, a large primary care study has found[1].

Type 3c diabetes, also known as diabetes of the exocrine pancreas, occurs following pancreatic disease when the pancreas becomes inflamed, or part of it is removed, and consequently insulin production is reduced.

In contrast, type 2 diabetes is the result of metabolic changes that affect how insulin is produced.

Failure to recognise this altered physiology may result in suboptimal treatment, the researchers explained, as patients with type 3c diabetes generally have worse glycaemic control and a greater requirement for insulin.

The study looked at more than 2 million primary care records in England for incident cases of adult-onset diabetes between 1 January 2005 and 31 March 2016. From those, the researchers identified 31,789 new diagnoses of adult-onset diabetes and found that diabetes following pancreatic disease was more common than type 1 diabetes, although type 2 diabetes had the highest incidence.

Out of the 559 cases of diabetes following pancreatic disease, 87.8% were classified by clinicians as type 2 diabetes and just 2.7% were diagnosed correctly with type 3c diabetes.

The study also found that people with type 2 diabetes and people with type 3c diabetes were both most frequently diagnosed with diabetes while at a body mass index compatible with obesity (30+), which, the researchers said, could partially explain why misdiagnoses are occurring.

“[This study] is another step towards a more stratified approach to disease management, ultimately towards practising personalised medicine,” said Simon de Lusignan, professor of primary care and clinical informatics at the University of Surrey and one of the authors of the study.

“If neither the clinician nor their patient are aware that the person has type 3c diabetes, then there may be a greater requirement for intensification of treatment.

This might be more than the clinician anticipated and, for the patient, more than they were led to believe was likely,” he explained.

“This study shows that [clinicians] should be able to flag people with previous pancreatic disease who also have diabetes within routine data; and can anticipate a different course for many and adapt our management accordingly,” he added.

Greater awareness of diabetes of the exocrine pancreas is required to appropriately manage this diabetes subgroup the researchers concluded.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2017.20203842

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • BNF and BNF for Children

    BNF and BNF for Children

    Now available as a 2 year print subscription to both the BNF and BNFC, ensuring you have the latest medicines information as it publishes and at a greatly reduced price.

    £262.50Buy now
  • Sport and Exercise Medicine for Pharmacists

    Sport and Exercise Medicine for Pharmacists

    All the information you need to provide patients with evidence-based advice on sports and exercise related health matters.

    £27.00Buy now
  • Introduction to Renal Therapeutics

    Introduction to Renal Therapeutics

    Introduction to Renal Therapeutics covers all aspects of drug use in renal failure. Shows the role of the pharmacist in patient care for chronic kidney disease.

    £38.00Buy now
  • Pathology and Therapeutics for Pharmacists

    Pathology and Therapeutics for Pharmacists

    An practical, integrated approach to the pathophysiological and pharmacotherapeutic principles underlying the treatment of disease.

    £54.00Buy now
  • Drugs and the Liver

    Drugs and the Liver

    Drugs and the Liver assists practitioners in making pragmatic choices for their patients. It enables you to assess liver function and covers the principles of drug use in liver disease.

    £38.00Buy now

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • Insulin test

Jobs you might like

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.